Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway

Influenza Other Respir Viruses. 2017 Sep;11(5):457-463. doi: 10.1111/irv.12459. Epub 2017 Jul 11.

Abstract

Background: Influenza A viruses (IAV) result in severe public health problems with worldwide each year. Overresponse of immune system to IAV infection leads to complications, and ultimately causing morbidity and mortality.

Objective: Curcumin has been reported to have anti-inflammatory ability. However, its molecular mechanism in immune responses remains unclear.

Methods: We detected the pro-inflammatory cytokine secretion and nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB)-related protein expression in human macrophages or mice infected by IAV with or without curcumin treatment.

Results: We found that the IAV infection caused a dramatic enhancement of pro-inflammatory cytokine productions of human macrophages and mice immune cells. However, curcumin treatment after IAV infection downregulated these cytokines production in a dose-dependent manner. Moreover, the NF-κB has been activated in human macrophages after IAV infection, while administration of curcumin inhibited NF-κB signaling pathway via promoting the expression of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα), and inhibiting the translocation of p65 from cytoplasm to nucleus.

Conclusions: In summary, IAV infection could result in the inflammatory responses of immune cells, especially macrophages. Curcumin has the therapeutic potentials to relieve these inflammatory responses through inhibiting the NF-κB signaling pathway.

Keywords: Influenza A viruses (IAV); acute lung injury; curcumin; inflammation; nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Curcumin / administration & dosage
  • Curcumin / pharmacology*
  • Cytokines / drug effects
  • Cytokines / genetics
  • Cytokines / metabolism
  • Dogs
  • Down-Regulation
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects
  • Influenza A Virus, H1N1 Subtype / immunology
  • Macrophage Activation / drug effects*
  • Macrophages / drug effects
  • Macrophages / immunology
  • Madin Darby Canine Kidney Cells
  • Mice
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Orthomyxoviridae Infections / drug therapy
  • Orthomyxoviridae Infections / immunology*
  • Orthomyxoviridae Infections / metabolism
  • Orthomyxoviridae Infections / virology
  • Pneumonia / drug therapy
  • Pneumonia / immunology
  • Signal Transduction / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • NF-kappa B
  • Curcumin